Artelo Biosciences (ARTL) EPS (Basic) Growth (3y) (2017 - 2025)
Powered by 
Analysis
Artelo Biosciences (ARTL) EPS (Basic) Growth (3y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 19.50% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -129.90% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 6.85% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 11.71% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 86.03% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 18.44% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 36.73% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -45.60% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 67.51% |
| 10 | Artelo Biosciences | 120,340.96 | -479,659.04 | - | 10.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.95% |
| Sep 30, 2025 | -5.54% |
| Jun 30, 2025 | -4.57% |
| Mar 31, 2025 | -2.96% |
| Nov 30, 2021 | 92.94% |
| May 31, 2021 | 29.00% |
| Feb 28, 2021 | 35.53% |
| Nov 30, 2020 | 1.41% |
| Aug 31, 2020 | -51.63% |
| May 31, 2020 | -60.91% |
| Feb 29, 2020 | -239.51% |
| Nov 30, 2019 | -276.11% |
| Aug 31, 2019 | -405.32% |
| May 31, 2019 | -386.74% |
| Feb 28, 2019 | -320.15% |
| Nov 30, 2018 | -171.04% |
| Aug 31, 2018 | -354.90% |
| May 31, 2018 | -385.61% |
| Feb 28, 2018 | -305.71% |
| Nov 30, 2017 | -318.62% |